<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03663478</url>
  </required_header>
  <id_info>
    <org_study_id>TQL Catheters</org_study_id>
    <nct_id>NCT03663478</nct_id>
  </id_info>
  <brief_title>Continuous TQL Block for Elective Cesarean Section</brief_title>
  <official_title>Ultrasound-guided Transmuscular Quadratus Lumborum Catheters for Elective Caesarean Section. A Double Blind, Randomise, Placebo Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate whether it is possible to prolong time to first
      opioid with the TQL block by inserting catheters bilaterally, providing continuous analgesia,
      in patients undergoing elective CS. Our hypothesis is that it will be possible to
      significantly extend time to first opioid with the blockade by 66.6%, increasing it from a
      mean of 5.6 hours to a mean of 10 hours.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 4, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to first opioid</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>The time from catheters placement to the administration of opioids</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity (NRS 0-10/10)</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>NRS (numeric rating scale) score in the study period at 3, 6, 9, 12 and 24 hours postoperatively. In addition, NRS score will be recorded electronically on all morphine administrations, since all patients must enter their NRS score on the Patient-Controlled Analgesia (PCA) pump display prior to administration of the PCA boluses. NRS is a pain scale where the patient gives her pain a number from 0-10, where 0 is no pain and 10 is the worst pain imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total morphine consumption.</measure>
    <time_frame>24 hours</time_frame>
    <description>Morphine consumption at 3, 6, 9, 12 and 24 postoperative hours (data from PCA pump and patient medical record).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Catheter displacement.</measure>
    <time_frame>24 hours</time_frame>
    <description>Frequency of displacement of catheters (early displacement evaluated after 2 hours (T2), late displacement evaluated after 24 hours (T24)).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with application of the catheters.</measure>
    <time_frame>24 hours</time_frame>
    <description>NRS 0-10/10 during placement of catheters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The degree of morphine-related side effects (PONV, itching, fatigue, etc.).</measure>
    <time_frame>24 hours</time_frame>
    <description>On a scale from 0-3, where 0 is none, 1 is mild, 2 is moderate and 3 is severe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from operation to ambulation.</measure>
    <time_frame>24 hours</time_frame>
    <description>Time from operation to ambulation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Anesthesia, Local</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Isotonic saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>2 x 30 ml ropivacaine 0,2% and an elastomere pump with 200 ml ropivacaine 0,2%, infusion rate 8 ml/hour</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>2 x 30 mL isotonic saline and an elastomere pump with 200 ml isotonic saline, infusion rate 8 ml/hour</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18+ years of age.

          -  Scheduled for elective Caesarean Section in spinal anaesthesia.

          -  Have received thorough information, verbally and in written, and signed the &quot;Informed
             Consent&quot; form on participation in the trial.

        Exclusion Criteria:

          -  Inability to cooperate

          -  Inability to understand Danish

          -  Allergy to local anaesthetics or opioids

          -  Excessive daily intake of opioids, according to the discretion of the investigator

          -  Local infection at the site of injection or systemic infection

          -  Difficult visualisation of muscular and fascial structures on ultrasound, necessary to
             correct blockade and catheter placement.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Børglum, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Zealand University Hospital, University of Copenhagen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jens Børglum, MD PhD</last_name>
    <phone>+4530700120</phone>
    <email>jens.borglum@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gudny Steingrimsdottir, MD</last_name>
    <phone>+4561714389</phone>
    <email>dr.gudny@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of anaesthesiology</name>
      <address>
        <city>Roskilde</city>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens Børglum, MD PhD</last_name>
      <phone>30700120</phone>
      <email>jens.borglum@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Gudny Steingrimsdottir, MD</last_name>
      <phone>+4561714389</phone>
      <email>dr.gudny@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>September 4, 2018</study_first_submitted>
  <study_first_submitted_qc>September 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2018</study_first_posted>
  <last_update_submitted>July 16, 2019</last_update_submitted>
  <last_update_submitted_qc>July 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

